Concepedia

Indira Elangovan

IE

Statistics

Publications

6

Citations

256

H-Index

6

Active since

2011

Affiliations

University of Illinois Chicago(Current)

Indira Elangovan is an author at University of Illinois Chicago specializing in oncology, cancer cell signaling, and life sciences.

Publications per year

2011–2025

6

Publications

6

DDB2 Suppresses Epithelial-to-Mesenchymal Transition in Colon Cancer

Nilotpal Roy, Prashant V. Bommi, Uppoor G. Bhat et al. · Cancer Research · 2013 · 67 citations

, , +17

Targeting receptor for advanced glycation end products (RAGE) expression induces apoptosis and inhibits prostate tumor growth

Indira Elangovan, Sivasakthivel Thirugnanam, Aoshuang Chen et al. · Biochemical and Biophysical Research Communications · 2011 · 65 citations

, , +14

FOSL1 Promotes Kras-induced Lung Cancer through Amphiregulin and Cell Survival Gene Regulation

Indira Elangovan, Michelle Vaz, Chandramohan R. Tamatam et al. · American Journal of Respiratory Cell and Molecular Biology · 2017 · 58 citations · Full text

, , +17

c-Jun Is Required for Nuclear Factor-κB–Dependent, LPS-Stimulated Fos-Related Antigen-1 Transcription in Alveolar Macrophages

Rakesh K. Mishra, Haranatha R. Potteti, Chandramohan R. Tamatam et al. · American Journal of Respiratory Cell and Molecular Biology · 2016 · 31 citations · Full text

, , +17

Effectiveness and Impact of Maternal RSV Immunization and Nirsevimab on Medically Attended RSV in US Children

Heidi L. Moline, Ayzsa Tannis, Leah Goldstein et al. · JAMA Pediatrics · 2025 · 19 citations · Full text

, , +17

1–5 of 6